ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.3 | 0.1 | 0.1 |
| Total income | 0.3 | 0.1 | 0.1 |
| Profit before exceptional items & tax | -0.1 | -0.0 | 0.0 |
| Profit before tax | -0.1 | -0.0 | 0.0 |
| Net profit | -0.2 | -0.0 | 0.0 |
| Operating margin | -33.3% | 0.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | +200.00% |
|---|
BSE results filing, NSE: PRISMMEDI. Figures extracted from the filing.
Prism Medico and Pharmacy Ltd: key numbers
- Share price
- ₹37.47
- Market cap
- ₹50.82 Cr
- Revenue (annual)
- ₹2.44 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- -590.3×Sector 46.8×
- Promoter holding
- 29.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prism Medico and Pharmacy Ltd
All →Prism Medico and Pharmacy Q2 FY27 Results: Turns Profitable, Net Profit ₹0.2 Cr
Prism Medico and Pharmacy reported unaudited standalone results for the quarter ended September 30, 2026. Quarterly net profit was Rs.22.65 lakhs, versus a loss a year earlier.
- Key figure
- Net profit ₹0.2 Cr
Prism Medico and Pharmacy Board Meeting Date
Prism Medico and Pharmacy will hold a board meeting on November 5, 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from October 1 until November 7, 2026.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31. This is a routine filing.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy Limited has informed that no interest, dividend, or principal is payable on non-convertible securities for the quarter ending December 31, 2026.
Prism Medico and Pharmacy Management Change
Prism Medico and Pharmacy Limited re-appointed Davender Singh as a Non-Executive Non-Independent Director. The company also updated its statutory and secretarial auditor appointments.